Boston, MA -- (SBWIRE) -- 12/04/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Northwest Biotherapeutics, Inc (NASDAQ:NWBO), CYS Investments Inc (NYSE:CYS), KeyCorp (NYSE:KEY), AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTCBB:AMBS)
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) opened its shares at the price of $4.77 for the day. Its closing price was $4.46 after losing -6.50% for the day. The company traded with the total volume of 1.03 million shares, while its average trading volume remained 1.35 million shares. The beta of NWBO stands at 1.61. Northwest Biotherapeutics, Inc. is a development-stage company. The Company focuses on discovering, developing, and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer.
Has NWBO Found The Bottom and Ready To Move Up? Find Out Here
CYS Investments Inc (NYSE:CYS) percentage change plunged -0.90% to close at $7.74 with the total traded volume of 3.19 million shares, and average volume of 3.19 million. The 52 week range of the stock remained $6.74 - $13.36, while its day lowest price was $7.67 and it hit its day highest price at $7.84. CYS Investments, Inc. is a specialty finance company created with the objective of achieving consistent risk-adjusted investment income.
Has CYS Found The Bottom And Ready To Gain Momentum? Find Out Here
KeyCorp (NYSE:KEY) started its trading session with the price of $12.74 and closed at $12.58 by losing -1.41%. KEY stocks traded with total volume of 11.97 million shares, while the average trading volume remained 10.01 million shares. The beta of KEY stands at 0.97. Day range of the stock was $12.48 -$12.79. KeyCorp, is a bank holding company. It is a bank-based financial services company. KeyCorp is the parent holding company for KeyBank National Association (KeyBank), its principal subsidiary, through which most of its banking services are provided.
Why Should Investors Buy KEY After the Recent Fall? Just Go Here and Find Out
AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTCBB:AMBS) ended its day with the gain of +5.38% and closed at the price of $0.049 after opening at $0.0471. Stock traded during its last trading session with the total volume of 4.89 million shares. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
Why Should Investors Buy AMBS After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)